PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test CentersBusiness Wire • 03/23/22
Lucid Diagnostics to Hold a Business Update Conference Call on March 28, 2022Business Wire • 03/07/22
PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommodate EsoGuard Testing GrowthBusiness Wire • 03/03/22
Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of DirectorsBusiness Wire • 02/15/22
Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools ConferenceBusiness Wire • 02/10/22
Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth ConferenceBusiness Wire • 01/06/22
PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealthBusiness Wire • 12/01/21
Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services ForumBusiness Wire • 11/17/21
PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial ResultsBusiness Wire • 11/16/21
PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021Business Wire • 11/03/21
Lucid Diagnostics' EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year” AwardBusiness Wire • 10/28/21
ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific OfficerBusiness Wire • 10/21/21